Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biogen Names R&D VP | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Biogen Names R&D VP

Michael Ehlers will lead company’s efforts to create transformational medicines business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Biogen has appointed Michael Ehlers executive vice president, research and development.

Dr. Ehlers will oversee Biogen’s global research, drug discovery, clinical development, and medical affairs functions, defining the strategic direction for the company’s R&D organization and leading its efforts to develop therapies for patients with few or no treatment options. Dr. Ehlers will report to George Scangos, chief executive officer, and will be a member of the Biogen management team. He will begin his tenure at Biogen in late May.

“I am thrilled to have Mike join us,” said Dr. Scangos. “We conducted a thorough, global search, and I am convinced that we have found the right leader to build on our already outstanding R&D team. Mike is a brilliant neuroscientist, having made major contributions to our understanding of the biology of neurons; he is an established R&D leader who has excelled in both academic and corporate settings; and he has demonstrated the ability to translate science into important new medicines.”

Dr. Ehlers joins Biogen from Pfizer, where he served as group senior vice president for BioTherapeutics R&D and chief scientific officer for the company’s Neuroscience and pain research unit. Dr. Ehlers led Pfizer’s Cambridge and Boston research sites and was responsible for a network of collaborations with major academic and government institutions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics